Knee joint replacement follow up study in patients with knee osteoarthritis which participated to the CL3-12911-018 study.

• Conditions: OsteoarthritisThe medical condition investigated in the CL3-12911-018 study was osteoarthritis. The applied CL3-12911-040 trial, CL3-12911-018 follow-up study, is thus performed in osteoarthritic patients.; MedDRA version: 14.1Level: PTClassification code 10031161Term: OsteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2011-004046-18-AT
• Lead Sponsor: Institut de Recherches Internationales Servier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-30
• Last Update Posted: 11 August 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 1206

Inclusion Criteria

Patients included in the CL3-12911-018 study and having received the CL3-12911-018 study treatment (Strontium Ranelate 1g/2g or placebo) for at least one year (at least 365 days of treatment during the CL3-12911-018 study).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 772
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 434

Exclusion Criteria

Unlikely to cooperate in the study (such as patients suffering from dementia).
Patients unable to provide the information requested by the study.
Refusal to provide the study’s informed consent.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified